-
$VBIO: Q2 Setup — Entolimod Regulatory Momentum vs. Cash Burn earnings_pre · 2026-08-13-VBIO · Aug 13, 4:03 PM ETValion Bio reports Q2 2026 results; focus shifts to cash runway and Ukraine radiation injury data timeline.
-
$MGRX: Q2 Earnings Preview — Nuclea Merger & Nasdaq Compliance earnings_pre · 2026-08-13-MGRX · Aug 13, 3:54 PM ETPre-market focus on the definitive business combination with Nuclea Energy and the 180-day Nasdaq compliance extension.